By Edward Winnick

SAN FRANCISCO (GenomeWeb News) - Gen-Probe officials told investors Monday at the JP Morgan Healthcare Conference that although the firm expects product sales growth in the high-single digits for 2011, sales are expected to be in the double digits for several years afterward as the firm expands the menu for its new Panther molecular diagnostics system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.